Invest in GATC Health
GATC Health is revolutionizing the pharmaceutical industry with our patented AI platform. We model human physiology to accurately forecast a drug's success rate before any animal or human trials even begin.
Medical industry is Not Just Slow, It's Broken
A staggering 12 years and $2.6 billion — that's the usual cost to bring a drug to the market.
80-90%
of drug development failures happen because the drug simply doesn't work as intended in clinical trials. That's a high-risk game, and most players are losing.
12 Years
The drug discovery process can take up to 12 years and cost around $2.6 billion. What's worse? The longer it takes, the more expensive it gets. Regulatory hurdles add more years and dollars, making it a slow and costly ordeal.
Pioneering the Future
Bridging the AI Gap in Pharmaceutical Discovery
The vast majority of traditional drug discovery methods are obsolete, marred by inefficiencies in both time and capital. GATC Health is revolutionizing this landscape. Utilizing specialized machine learning algorithms, we have crafted a highly efficient and accurate system that transcends current market limitations.
(Est Watch time －70 seconds)
Our Proprietary Technology
The MAT
™
Platform
Multiomics Advanced Technology ™ ― The Apex of Drug Discovery Innovation
The MAT™ platform represents the zenith of interdisciplinary scientific innovation, a harmonious amalgamation of neural networks and deep machine learning algorithms. This is not merely technology; it is the vanguard of drug develoment.
1.
1.
Surpassing Industry Standards by an Order of Magnitude
GATC Health's MAT platform is fast, accurate, and safe. We predict drug success with 85% accuracy and failure with 91%, saving time and enhancing drug safety.
1.
Surpassing Industry Standards by an Order of Magnitude
GATC Health's MAT platform is fast, accurate, and safe. We predict drug success with 85% accuracy and failure with 91%, saving time and enhancing drug safety.
2.
2.
Unparalleled Data Processing: 400 Trillion Data Points in Minutes
Our platform processes 400 trillion genetic data points in just seven minutes, accelerating drug discovery with unparalleled precision.
2.
Unparalleled Data Processing: 400 Trillion Data Points in Minutes
Our platform processes 400 trillion genetic data points in just seven minutes, accelerating drug discovery with unparalleled precision.
3.
3.
Annual Production of High-Value Drug Candidates
The MAT Platform can produce 10-12 drug candidates annually, each potentially worth hundreds of millions, setting a new standard in healthcare solutions.
3.
Annual Production of High-Value Drug Candidates
The MAT Platform can produce 10-12 drug candidates annually, each potentially worth hundreds of millions, setting a new standard in healthcare solutions.
4.
4.
An Expansive and Growing Intellectual Property Portfolio
Our growing IP portfolio includes groundbreaking drug candidates and innovative health reports, all powered by the MAT AI platform.
4.
An Expansive and Growing Intellectual Property Portfolio
Our growing IP portfolio includes groundbreaking drug candidates and innovative health reports, all powered by the MAT AI platform.
5.
5.
Unmatched Accuracy in Drug Safety and Efficacy
With 90% of drug candidates failing in traditional clinical trials, our platform eliminates the guesswork even before pre-clinical testing begins. The result ― massive savings in R&D and a faster route to effective, safe medications.
5.
Unmatched Accuracy in Drug Safety and Efficacy
With 90% of drug candidates failing in traditional clinical trials, our platform eliminates the guesswork even before pre-clinical testing begins. The result ― massive savings in R&D and a faster route to effective, safe medications.
Endorsements from Industry Leaders
Hear what respected professionals in the healthcare and tech industries have to say about GATC Health.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson, PhD
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson, PhD
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson, PhD
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson, PhD
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
Herb Boyer
Co-founded Genentech, the first biotech company to go public, purchased in 2009 by Swiss giant Roche for $46.8 billion
I believe their platform is the next generation of technology to discover new therapeutics that will treat diseases more effectively than ever before.
Patrick Lilley
CEO of Liquid Biosciences
What GATC did was produce compounds that hit all four of the causal targets that we identified. I have not ever seen that in the industry.
Lin Yu, PhD
Former Managing Director Healthcare Investment Banking, Oppenheimer
I believe GATC’s technology will save years of R&D time as well as significant amount of cost typically associated with such processes, creating value for all stakeholders in the healthcare community.
Tomas Philipson
Former Acting Chairman of the White House Council of Economic Advisers
I believe this platform is an extraordinarily powerful tool for firms investing in biopharma.
Mark Palaima
Former Chief Architect at eBay
This is true artificial intelligence, which understands complex biological systems at a cellular level. I believe GATC Health is positioned to radically transform the fields of predictive diagnostics and the creation of therapeutics that are safer, more effective and focused on restoring homeostasis, not just symptom relief.
GATC Health vs Competitors
Our Expert Team
Our Expert Team
The Minds Behind the Innovation
The Minds Behind the Innovation
Meet the remarkable team steering GATC Health into the future. Our leadership is comprised of seasoned professionals from technology, science, and finance sectors.
Meet the remarkable team steering GATC Health into the future. Our leadership is comprised of seasoned professionals from technology, science, and finance sectors.
John Stroh
Chief Executive Officer
READ BIO
John Stroh
Chief Executive Officer
READ BIO
Jayson Uffens
Chief Technology Officer
READ BIO
Jayson Uffens
Chief Technology Officer
READ BIO
Ian Jenkins
Chief Science Officer
READ BIO
Ian Jenkins
Chief Science Officer
READ BIO
Jeff Moses
President
READ BIO
Jeff Moses
President
READ BIO
Vaishnavi Narayan
Principal AI Engineer
READ BIO
Vaishnavi Narayan
Principal AI Engineer
READ BIO
Tyrone Lam
Chief Operating Officer
READ BIO
Tyrone Lam
Chief Operating Officer
READ BIO
Robert Sorrentino, MD
Chief Medical Officer
READ BIO
Robert Sorrentino, MD
Chief Medical Officer
READ BIO
Eric J. Mathur
Chief Innovation Officer
READ BIO
Eric J. Mathur
Chief Innovation Officer
READ BIO
Michael Manahan
Chief Financial Officer
READ BIO
Michael Manahan
Chief Financial Officer
READ BIO
Waldemar Lernhardt, PhD
Vice President Scientific Operations
READ BIO
Waldemar Lernhardt, PhD
Vice President Scientific Operations
READ BIO
Chad Penry
Director of Business Development
READ BIO
Chad Penry
Director of Business Development
READ BIO
Robert Tinder, PhD
Head of Chemical Research
READ BIO
Robert Tinder, PhD
Head of Chemical Research
READ BIO
John Stroh
Chief Executive Officer
READ BIO
Jayson Uffens
Chief Technology Officer
READ BIO
Ian Jenkins
Chief Science Officer
READ BIO
Jeff Moses
President
READ BIO
Robert Sorrentino, MD
Chief Medical Officer
READ BIO
Vaishnavi Narayan
Principle AI Engineer
READ BIO
Tyrone Lam
Chief Operating Officer
READ BIO
Michael Manahan
Chief Financial Officer
READ BIO
Eric J. Mathur
Chief Innovation Officer
READ BIO
Waldemar Lernhardt, PhD
Vice President Scientific Operations
READ BIO
Chad Penry
Director of Business Development
READ BIO
Robert Tinder, PhD
Head of Chemical Research
READ BIO
Guiding Us Toward Excellence
Guiding Us Toward Excellence
Our Advisors and Mentors
Our Advisors and Mentors
Our board of advisors is a powerhouse of knowledge and experience. Comprising esteemed researchers, medical doctors, biotech executives, and policy experts, they offer invaluable guidance in steering GATC's mission.
Our board of advisors is a powerhouse of knowledge and experience. Comprising esteemed researchers, medical doctors, biotech executives, and policy experts, they offer invaluable guidance in steering GATC's mission.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Tomas Philipson, PhD
Health Policy and Pharma Advisor
READ BIO
Former Acting Chairman of the Council of Economic Advisers in the Trump administration
Former senior economic advisor to the head of the Food and Drug Association
Former senior economic advisor to the head of the Centers for Medicare & Medicaid Services
Professor of Public Policy Studies Emeritus at the Univ of Chicago Harris School of Public Policy
Chad Beyer, PhD
Science Advisor
READ BIO
25 years of CNS drug discovery and development experience
33 INDs; 70+ manuscripts; 2 blockbuster medications
NIDA; Wyeth; Ariel and Promentis Pharmaceuticals
John O'Reilly
Health Policy Advisor
READ BIO
Leader in healthcare, law, and business advisory.
Chairs UCLA Health System Board and University Medical Center of Southern Nevada.
Extensive experience in healthcare innovation and strategic planning.
Cum laude graduate in law and accounting, ex-military legal officer.
Jonathan Lakey, PhD
Chair of Scientific Advisory Board
READ BIO
Professor Emeritus, Surgery & Biomedical Engineering, UC Irvine School of Medicine
Diabetes and islet transplantation expert and co-developer of the Edmonton Protocol
International Speaker on islet transplantation, stem cell research and diabetes
500+ authored scientific papers
Dr. Jack Lewin
Medical Advisor
READ BIO
Administrator, Hawaii State Health Planning Development, Sr Advisor to Governor
Former CEO, American College of Cardiology, California Medical Assoc
Former President & CEO of Cardiovascular Research Foundation
Dr. Seema Gupta
Medical Advisor
READ BIO
Primary Care Physician with Veterans Administration (20 years).
Expert in Internal Medicine, Preventive Medicine, Public Health, Global Health.
Editorial Board of Internal Medicine Alerts (leading publication for medical providers).
Patrick Lilley
Science Advisor
READ BIO
CEO and Founder, Liquid Biosciences
Member Blockchain & AI Task Force
Inventor 75+ patents & trade secrets
Board Member, Mamogen, HepGene, LiquidLung
Mark Palaima
Technology Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Dr. Stanley Lewis
Medical Advisor
READ BIO
eBay—Chief Architect, Fellow—10 yrs.
Inkiru, Inc (Acquired by Walmart Labs)—Chief Scientist, Founder
Ismintis Systems —Founder
Gerald P. Curatola, D.D.S.
Business Development Advisor
READ BIO
Internationally recognized biological doctor, inventor, author, and wellness pioneer
Adj. Clinical Associate Professor, New York University College of Dentistry
Founder of Rejuvenation Health, medical and dental practices, and Revitin Oral Care.
Dr. David Kushner
Nuclear Radiology Specialist
READ BIO
35+ years as Nuclear Radiology Specialist / US Navy Physician
Fellow in Musculoskeletal imaging and Nuclear Medicine
Assistant professor at Uniform University of the Health Science
Herbert Boyer
Science Advisor
READ BIO
Co-founder Genentech (first biotech company to go public)
Co-discovered methods that founded genetic engineering.
Numerous awards including the Albert Lasker Award for Medical Research, Industrial Research Institute Achievement Award, the National Medal of Technology, National Medal of Science.
Richard Schatz, MD
Chair of Medical Advisor Board
READ BIO
Co-inventor of the coronary stent a nd international expert in interventional cardiology
Inducted into the National Academy of Inventors and won the prestigious Russ Prize for Bioengineering, considered the American Nobel Prize
Adjunct Professor of Medicine and Cardiology at Duke University
Lin Yu, PhD
Board of Directors
READ BIO
Former Managing Director Oppenheimer Healthcare Investment Banking
Former Managing Director at BTIG Healthcare Investment Banking
Ph.D. from Columbia University in chemical engineering focused on next-generation DNA sequencing technologies
Joseph Stauffer
Medical Advisor
READ BIO
CEO/Founder Alta Life Sciences, CMO Antibe Therapeutics, Chairman BioFuse Medical Technologies
Former Assistant Professor John Hopkins Medicine, FDA Medical Officer, Global Medical Director for Abbott Labs, U.S. Navy Medical.
Jayson Hymes
Medical Advisor
READ BIO
Fellow of the American College of Pain Medicine, Fellow of the American Society of Addiction Medicine, Assistant Clinical Professor Anesthesiology & Pain Medicine at USC School of Medicine
Former advisor to Office of National Drug Control Policy, the Medical Board of California, California Narcotics Officers Association, Los Angeles Field Division of the DEA.
Lets make an impact together
Lets make an impact together
Your Opportunity to Transform Medicine
Your Opportunity to Transform Medicine
If you're an investor looking for a groundbreaking opportunity, you've found it. GATC Health is a leader, not just another player in drug discovery.
We are the real value creators in the biotech ecosystem.
If you're an investor looking for a groundbreaking opportunity, you've found it. GATC Health is a leader, not just another player in drug discovery.
We are the real value creators in the biotech ecosystem.
Real Results, Fast
In less than two years, we have discovered novel five drug candidates to treat multiple neurological diseases. Our AI nails it 88% of the time, way above the industry average of less than 10%.
Real Results, Fast
In less than two years, we have discovered novel five drug candidates to treat multiple neurological diseases. Our AI nails it 88% of the time, way above the industry average of less than 10%.
Real Results, Fast
In less than two years, we have discovered novel five drug candidates to treat multiple neurological diseases. Our AI nails it 88% of the time, way above the industry average of less than 10%.
Speed and Precision
We process 400 trillion data points in just 8 minutes. That's not just technology; it's the future of medicine. Your investment accelerates this paradigm shift.
Speed and Precision
We process 400 trillion data points in just 8 minutes. That's not just technology; it's the future of medicine. Your investment accelerates this paradigm shift.
Speed and Precision
We process 400 trillion data points in just 8 minutes. That's not just technology; it's the future of medicine. Your investment accelerates this paradigm shift.
Good for Pharma, Great for You
We speed up the early stages of drug development by 11X. That saves big pharma big money and can mean great returns for you.
Good for Pharma, Great for You
We speed up the early stages of drug development by 11X. That saves big pharma big money and can mean great returns for you.
Good for Pharma, Great for You
We speed up the early stages of drug development by 11X. That saves big pharma big money and can mean great returns for you.
A Pipeline of Profits
Imagine 10-12 new drug candidates coming out each year, each potentially worth hundreds of millions. That's not just an investment; it's a portfolio of future profits.
A Pipeline of Profits
Imagine 10-12 new drug candidates coming out each year, each potentially worth hundreds of millions. That's not just an investment; it's a portfolio of future profits.
A Pipeline of Profits
Imagine 10-12 new drug candidates coming out each year, each potentially worth hundreds of millions. That's not just an investment; it's a portfolio of future profits.
An Elite Team
Our team isn't new to the game. We've got experience building world-class tech and AI solutions.
An Elite Team
Our team isn't new to the game. We've got experience building world-class tech and AI solutions.
An Elite Team
Our team isn't new to the game. We've got experience building world-class tech and AI solutions.
© 2024 GATC Health Corp. All rights reserved.
© 2024 GATC Health Corp. All rights reserved.
© 2024 GATC Health Corp. All rights reserved.